IRIDEX Corporation (IRIX:NASDAQ) closed at $0.754 on October 26, 2026, up 1.11% on the day. The stock trades 54.3% below its 52-week high of $1.65 and 23.6% above its 52-week low of $0.610. Over the past year, it lost 28.9%. IRIDEX Corporation is part of the Health Care sector (Biotechnology: Electromedical & Electrotherapeutic Apparatus).
In 252 trading sessions since October 24, 2025, IRIX closed higher on 100 days (40%). Its best day was October 7, 2026 (+29.41%) and its worst was March 27, 2026 (-26.67%). The stock moved 10% or more in a single session 7 times. It opened at least 5% above the previous day's high 1 time.
IRIDEX Corporation provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. The company offers laser consoles, such as Cyclo G6 laser system used for the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser systems, which are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. It also provides delivery devices, including TxCell scanning laser delivery system that allows the physicians to perform multi-spot pattern scanning; Slit Lamp Adapter, which allows the physicians to utilize a standard slit lamp in diagnosis and treatment procedures; and TruFocus laser indirect ophthalmoscopes for use in procedures to treat peripheral retinal disorders. In addition, the company offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system that delivers laser to treat glaucoma; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe Illuminate that is used in p...
Find more stocks like IRIX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.